Company intelligence / Profile preview

Aptuit

Greenwich, CT, United Statesx.com ↗

Ownership: Private
Employees: ~750
Development stage: Other

Overview

Aptuit provided integrated early discovery to mid-phase drug development services including drug design/discovery, API development/manufacture, solid state chemistry, CMC, preclinical and IND-enabling GLP/GMP programs. It was recognized for its scientific excellence and ability to combine CRO efficiency with large pharma capabilities. In 2017 it was acquired by Evotec[2][8].

Therapeutic areas: Neurology
Modalities: Small moleculeBiologic
Industry: Drug Discovery Services

Partnerships

Welsh, Carson, Anderson & Stowe (private equity partner)Laurus Labs in India (strategic relationship)

Beyond the preview

Go deeper on Aptuit.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aptuit.

Explore the full profile